NEWS
Extensive range of independently verified cell lines.
Amsbio has launched a new range of authenticated cell lines covering a wide range of tumours, tissues, and species.
With this addition of greater than 1000 independently verified human and animal cell lines, versatile primary and stem cells, the expanded...
Cambridge Wide Open Week 2026 preview
Cambridge Wide Open Week 2026 (CWOW) has unveiled details of its June 11–19 event as the life sciences festival expands across the UK’s innovation 'Golden Triangle' for the very first time.
Keynote speakers for the event include: former Minister for...
Reducing fluid control and automation complexity in pharma process development
Designing and building pharmaceutical processes or skids demands close coordination between mechanical, electrical and instrumentation, and automation engineering teams. Fragmented design and vendor selection can introduce challenges in integration and validation. Aligning these disciplines through compatible hardware, automation, and...
Investigating the causes of Rheumatoid Arthritis pain.
Amsbio reports how researchers from the Karolinska Institute, Stockholm, Sweden are using their Adeno Associated Virus (AAV) products in a groundbreaking investigation into the causes of Rheumatoid Arthritis pain.
Rheumatoid arthritis (RA) pain is not explained well by inflammation alone....
New iPSC Differentiation kits for neuroscience research
Amsbio has expanded its range of iPSC Differentiation Kits that provide fast and flexible generation of specific cell types without sacrificing cell purity.
New to market - Quick-Gliaâ„¢ product line consist of human induced pluripotent stem cell derived glial cells...
Fully defined 3D culture substrate for cancer research
Amsbio reports how researchers at the Graduate School of Medicine, Kyoto University (Japan) have cultured patient-derived colorectal cancer cells in 3D using their MatriMix 511 extracellular matrix (ECM).
In this study** the researchers demonstrated that MatriMix supported robust cancer organoid...
Your Clinicians Are Already in 2026. Is Your Field Force There Too?
Authored by Marina Hickson, Managing Director, Vivanti
Healthcare in Europe is entering a phase where artificial intelligence is moving from pilot projects to everyday clinical infrastructure. Hospitals and healthcare systems are increasingly deploying AI across diagnostics, triage, clinical documentation and...
Chemical breakthrough sheds light on origins of life
Researchers at the MRC Laboratory of Molecular Biology (LMB) have discovered a tiny RNA molecule that could explain how life on Earth began.
The findings, published in the journal Science, reveal the team has identified a remarkably small RNA...
Can brain health be predicted with a smartwatch?
Connected devices can gather valuable data to help prevent neurological and mental disorders, new study claims.
Smartphones or smartwatches could help detect early signs of neurological or mental illness, say researchers at the University of Geneva (UNIGE).
The team monitored participants...
Making Pharmaceuticals, Distributing Pharmaceuticals and Making Nutraceuticals 2026
Taking place at the Coventry Building Society Arena on 21-22 April 2026 and free to attend, Making Pharmaceuticals, Distributing Pharmaceuticals and Making Nutraceuticals are co-located events providing professionals from across pharmaceutical and nutraceutical supply chains with a platform for...
Beyond regulation: four AI trends transforming life sciences tech
Doron Sitbon, CEO of Dot Compliance, outlines four developments set to change how life-sciences organisations design, deploy and govern intelligent systems this year.
Artificial intelligence (AI) is becoming embedded into the fabric of quality, compliance and production systems and shaping...
Communication breakdown: soft skills are more important than ever in life sciences
By Ivan Wall, Professor of Regenerative Medicine at the University of Birmingham and co-director of Resilience, the UK’s Medicines Manufacturing Skills Centre of Excellence.
We all know or work with people who can be difficult to deal with and even...
£3 billion invested in Cambridge Biomedical Campus (CBC) growth
The county council has partnered with developer Prologis to support the expansion.
The committee heard that 67 acres of council-owned land is being put forward to allow the next phase of growth, aligned with delivery of the UK’s Modern Industrial...
Hydrogel could be personalised bone implant of the future
Researchers at ETH Zurich aim to use a jelly-like material to produce implants for rock-hard bones.
Bones broken in an accident usually heal on their own. But if the break is too severe or a bone tumour needs to be removed, surgeons insert an implant that enables the bone...
Pet cats could hold key to understanding breast cancer
The first study of multiple cancer types in cats has identified genetic changes that could help treat the condition in humans and animals.
The first study of multiple cancer types in cats has identified genetic changes that could help...
Neural interface pioneers win 2026 Queen Elizabeth Prize for Engineering
The 2026 Queen Elizabeth Prize for Engineering honours nine engineers whose pioneering work on modern neural interfaces has restored lost human function and had a lasting impact for people around the world.
The QEPrize has been awarded to Graeme Clark,...
Why humans are active during the day
Scientists have discovered why humans are not nocturnal, revealing that the answer lies in the genes.Â
Early mammalian ancestors were nocturnal, sleeping during the day while the dinosaurs dominated the land.
However, some mammalian lineages, including human ancestors, independently transitioned to...
Europa Biosite Introduces Rapid RNA Production Technologies
Europa Biosite has announced a new strategic distribution partnership with Quantoom Biosciences, a leading manufacturer of innovative mRNA technologies for global healthcare advancement supporting next generation vaccines and therapeutics. The agreement provides access to Quantoom’s pioneering research RNA production...
Europa Biosite Acquires Stratech Scientific, Expanding Their Product Offering and Strengthening UK Customer Reach
Europa Biosite, a leading pan-European life science distribution group, today announced the acquisition of Stratech Scientific Limited by its UK subsidiary, Cambridge Bioscience. Stratech Scientific is a well-respected and long-established UK life science distributor, known for its high-quality research...
Transduction-ready viral particles
Amsbio offers a comprehensive range of pre-made lentiviral particles for delivering target genes into most types of dividing and non-dividing mammalian cells in vitro and in vivo.
Lentiviral particles provide long-term, stable expression of genes, making them ideal for stable...
Field-Ready, Science-Smart: Training the Next Generation of Pharma Reps
Marina Hickson Managing Director, Vivanti February 24, 2026
Pharmaceutical innovation exists to improve patient outcomes. Yet between laboratory discovery and patient benefit lies a critical intermediary: conversation. The way clinical evidence is explained, challenged and contextualised in discussions with healthcare...
Highly efficient kit yields significant populations of pure myogenic cells.
Amsbio has introduced an expanded range of Skeletal Muscle Differentiation Kits designed to reproducibly convert pluripotent or embryonic stem cells into myoblasts with high regenerative potential.
Using a simple 3-step process of media changes and cell passaging – these advanced...
The science of aging: from cellular mechanisms to clinical potential
Aging is an unavoidable aspect of human biology. As with many biological processes, the inevitable changes which occur as we age are not driven by a single, underlying cause, but an accumulation of interconnected biological mechanisms. These result in...
Effect of iPS cell culture medium on differentiation efficiency
Researchers at the Cira Foundation (Kyoto, Japan) have published an informative study** that highlights how defined culture conditions using Amsbio StemFitâ„¢ Basic03 medium coupled with a supportive matrix (iMatrix-511) contribute to controlling hiPSC behaviour and differentiation efficiency.
The study presents...
Reference standards improve AAV production.
Amsbio announces a new range of well characterized Adeno-Associated Virus (AAV) reference standards that enable researchers to significantly improve their AAV production processes.
Adeno-associated virus can be engineered to transport DNA of interest to target cells, without any viral genes...
Training the medicine makers of tomorrow: How virtual reality is securing the UK’s life sciences future
Ivan Wall, is co-director of Resilience, a two-year, £4.3 million UK government scheme using VR to educate the next generation of medicine makers.
As the world marks International Day of Education on 24 January, the UK faces a stark reality:...
Without the right infrastructure, the UK risks falling behind in life sciences
Dr Kath Mackay, Chief Scientific Officer at Bruntwood SciTech, insists that investment in scientific talent and research is not enough on its own. To stay globally competitive in life sciences, the UK must invest in the infrastructure and ecosystems...
UK spin-out raises £2m for gene-editing tool
A UK company that has developed a novel gene-editing tool has raised £2m ($2.7m) to expand its commercial work developing bacteria strains and adapt its tool for use with human and animal cells.
Forge Genetics, a spin-out from the University...
New National Laboratories open in Guildford
LGC Group, a global leader in life sciences, diagnostics, and analytical solutions, has officially opened its new state-of-the-art National Laboratories facility in Guildford.
This £20 million investment strengthens the UK’s scientific infrastructure and signals long-term private sector commitment to the...
Award winner discusses potential of retinal organoids.
In a new guest blog post – Dr Owen Jones, winner of the Amsbio 2024 ISSCR Travel Grant, reflects on his work developing and applying human stem cell–derived retinal organoid models for disease research and therapeutic discovery. Amsbio is...
